Pancreaze

Active Ingredient(s): Pancrelipase
FDA Approved: * April 12, 2010
Pharm Company: * ORTHO MCNEIL JANSSEN
Category: Enzymes

An amylase (/æmlez/) is an enzyme that catalyses the hydrolysis of starch (Latin amylum) into sugars. Amylase is present in the saliva of humans and some other mammals, where it begins the chemical process of digestion. Foods that contain large amounts of starch but little sugar, such as rice and potatoes, may acquire a slightly sweet taste as they are chewed because amylase degrades some of their starch into sugar. The pancreas and salivary gland make amylase (alpha amylase) to hydrolys... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Pancreaze McNEIL;MT;16
Pancreaze (Pancrelipase Lipase 16800 [usp'u] / Pancrelipase Amylase 70000 [usp'u] / Pancrelipase Protease 40000 [usp'u])
NDC: 50458-343
Labeler:
Janssen Pharmaceuticals, Inc.
Pancreaze (Pancrelipase Lipase 4200 [usp'u] / Pancrelipase Amylase 17500 [usp'u] / Pancrelipase Protease 10000 [usp'u])
NDC: 50458-341
Labeler:
Janssen Pharmaceuticals, Inc.
Pancreaze (Pancrelipase Lipase 10500 [usp'u] / Pancrelipase Amylase 43750 [usp'u] / Pancrelipase Protease 25000 [usp'u])
NDC: 50458-342
Labeler:
Janssen Pharmaceuticals, Inc.
Pancreaze (Pancrelipase Lipase 21000 [usp'u] / Pancrelipase Amylase 61000 [usp'u] / Pancrelipase Protease 37000 [usp'u])
NDC: 50458-346
Labeler:
Janssen Pharmaceuticals, Inc.
Pancreaze Oral Capsule, Delayed Release
NDC: 50458-347
Labeler:
Janssen Pharmaceuticals, Inc.
Pancreaze Oral Capsule, Delayed Release
NDC: 62541-401
Labeler:
Vivus, Inc.
Pancreaze Oral Capsule, Delayed Release
NDC: 62541-402
Labeler:
Vivus, Inc.
Pancreaze Oral Capsule, Delayed Release
NDC: 62541-403
Labeler:
Vivus, Inc.
Pancreaze Oral Capsule, Delayed Release
NDC: 62541-404
Labeler:
Vivus, Inc.
Pancreaze Oral Capsule, Delayed Release
NDC: 62541-405
Labeler:
Vivus, Inc.